Article info

Download PDFPDF

Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Authors

  • Roberta Noseda Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Raffaela Bertoli Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Laura Müller Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland PubMed articlesGoogle scholar articles
  • Alessandro Ceschi Division of Clinical Pharmacology and ToxicologyInstitute of Pharmacological Sciences of Southern Switzerland Ente Ospedaliero Cantonale, Via Tesserete 46 6903 Lugano Switzerland Department of Clinical Pharmacology and ToxicologyUniversity Hospital Zurich Zurich Switzerland PubMed articlesGoogle scholar articles
  1. a +41 91 811 63 00 roberta.noseda{at}eoc.ch
  2. b raffaela.bertoli{at}eoc.ch
  3. c laura.mueller{at}eoc.ch
  4. d alessandro.ceschi{at}eoc.ch
View Full Text

Citation

Noseda R, Bertoli R, Müller L, et al
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Publication history

  • Received December 13, 2018
  • Accepted April 22, 2019
  • First published May 2, 2019.
Online issue publication 
May 02, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.